These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32208397)

  • 1. Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.
    Kitagawa K; Toyoda K; Kitazono T; Nishikawa M; Nanto S; Ikeda Y; Abe K; Ogawa A
    Cerebrovasc Dis; 2020; 49(2):152-159. PubMed ID: 32208397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III.
    Kitazono T; Kamouchi M; Matsumaru Y; Shirai T; Takita A; Kuroda T; Kimura K
    Cerebrovasc Dis; 2023; 52(6):720-729. PubMed ID: 37011599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
    Ogawa A; Toyoda K; Kitagawa K; Kitazono T; Nagao T; Yamagami H; Uchiyama S; Tanahashi N; Matsumoto M; Minematsu K; Nagata I; Nishikawa M; Nanto S; Abe K; Ikeda Y;
    Lancet Neurol; 2019 Mar; 18(3):238-247. PubMed ID: 30784555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III).
    Kitazono T; Kamouchi M; Matsumaru Y; Nakamura M; Umemura K; Matsuo H; Koyama N; Tsutsumi J; Kimura K
    J Atheroscler Thromb; 2023 Mar; 30(3):222-236. PubMed ID: 35599000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Antiplatelet Therapy and Clinical Outcomes of Japanese Patients With Acute Myocardial Infarction　- Results From the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
    Yasuda S; Honda S; Takegami M; Nishihira K; Kojima S; Asaumi Y; Suzuki M; Kosuge M; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K;
    Circ J; 2019 Jul; 83(8):1633-1643. PubMed ID: 31204353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
    Shoji S; Sawano M; Sandhu AT; Heidenreich PA; Shiraishi Y; Ikemura N; Ueno K; Suzuki M; Numasawa Y; Fukuda K; Kohsaka S
    JAMA Netw Open; 2020 Apr; 3(4):e202004. PubMed ID: 32239221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trial.
    Nagao T; Toyoda K; Kitagawa K; Kitazono T; Yamagami H; Uchiyama S; Tanahashi N; Matsumoto M; Minematsu K; Nagata I; Nishikawa M; Nanto S; Abe K; Ikeda Y; Ogawa A
    Expert Opin Pharmacother; 2018 Apr; 19(6):529-535. PubMed ID: 29463150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.
    Kitazono T; Toyoda K; Kitagawa K; Nagao T; Yamagami H; Uchiyama S; Tanahashi N; Matsumoto M; Minematsu K; Nagata I; Nishikawa M; Nanto S; Ikeda Y; Shirai T; Abe K; Ogawa A;
    J Atheroscler Thromb; 2021 Feb; 28(2):169-180. PubMed ID: 32493881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke.
    Uchiyama S; Tanahashi N; Minematsu K;
    Cerebrovasc Dis; 2012; 34(3):229-39. PubMed ID: 23018233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
    Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
    Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
    Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
    Toyoda K; Yamagami H; Kitagawa K; Kitazono T; Nagao T; Minematsu K; Uchiyama S; Tanahashi N; Matsumoto M; Nagata I; Nishikawa M; Nanto S; Shirai T; Abe K; Ikeda Y; Ogawa A;
    Stroke; 2021 Apr; 52(4):1234-1243. PubMed ID: 33563017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial.
    Aradi D; Gross L; Trenk D; Geisler T; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Ruzsa Z; Ungi I; Rizas KD; May AE; Mügge A; Zeiher AM; Holdt L; Huber K; Neumann FJ; Koltowski L; Huczek Z; Hadamitzky M; Massberg S; Sibbing D
    Eur Heart J; 2019 Jun; 40(24):1942-1951. PubMed ID: 31226213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter research of bleeding risk between prasugrel and clopidogrel in Japanese patients with coronary artery disease undergoing percutaneous coronary intervention.
    Tokimasa S; Kitahara H; Nakayama T; Fujimoto Y; Shiba T; Shikama N; Nameki M; Himi T; Fukushima KI; Kobayashi Y
    Heart Vessels; 2019 Oct; 34(10):1581-1588. PubMed ID: 30944971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization.
    Park KH; Jeong MH; Kim HK; Ahn TH; Seung KB; Oh DJ; Choi DJ; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Kim KB; Kim YJ; Cha KS; Oh SK; Chae JK;
    J Cardiol; 2018 Jan; 71(1):36-43. PubMed ID: 28673508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study.
    Saito S; Isshiki T; Kimura T; Ogawa H; Yokoi H; Nanto S; Takayama M; Kitagawa K; Nishikawa M; Miyazaki S; Nakamura M
    Circ J; 2014; 78(7):1684-92. PubMed ID: 24759796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Faggioni M; Baber U; Chandrasekhar J; Sartori S; Weintraub W; Rao SV; Vogel B; Claessen B; Kini A; Effron M; Ge Z; Keller S; Strauss C; Snyder C; Toma C; Weiss S; Aquino M; Baker B; Defranco A; Bansilal S; Muhlestein B; Kapadia S; Pocock S; Poddar KL; Henry TD; Mehran R
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):53-60. PubMed ID: 30656812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.
    Blin P; Dureau-Pournin C; Benichou J; Bonello L; Dallongeville J; Danchin N; Falissard B; Thomas-Delecourt F; Jové J; Lassalle R; Droz C; Moore N
    Atherosclerosis; 2019 Feb; 281():98-106. PubMed ID: 30658197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Paciaroni M; Ince B; Hu B; Jeng JS; Kutluk K; Liu L; Lou M; Parfenov V; Wong KSL; Zamani B; Paek D; Min Han J; Del Aguila M; Girotra S
    Cardiovasc Ther; 2019; 2019():1607181. PubMed ID: 31867054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.